Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design, synthesis and biological evaluation of antiparasitic dinitroaniline-ether phospholipid hybrids.
Roussaki M, Magoulas GE, Fotopoulou T, Santarem N, Barrias E, Pöhner I, Luelmo S, Afroudakis P, Georgikopoulou K, Nevado PT, Eick J, Bifeld E, Corral MJ, Jiménez-Antón MD, Ellinger B, Kuzikov M, Fragiadaki I, Scoulica E, Gul S, Clos J, Prousis KC, Torrado JJ, Alunda JM, Wade RC, de Souza W, Cordeiro da Silva A, Calogeropoulou T. Roussaki M, et al. Among authors: scoulica e. Bioorg Chem. 2023 Sep;138:106615. doi: 10.1016/j.bioorg.2023.106615. Epub 2023 May 19. Bioorg Chem. 2023. PMID: 37244229
Correction to: Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates.
Maraki S, Mavromanolaki VE, Magkafouraki E, Moraitis P, Stafylaki D, Kasimati A, Scoulica E. Maraki S, et al. Among authors: scoulica e. Infection. 2022 Dec;50(6):1639. doi: 10.1007/s15010-022-01918-4. Infection. 2022. PMID: 36201154 No abstract available.
Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates.
Maraki S, Mavromanolaki VE, Magkafouraki E, Moraitis P, Stafylaki D, Kasimati A, Scoulica E. Maraki S, et al. Among authors: scoulica e. Infection. 2022 Apr;50(2):467-474. doi: 10.1007/s15010-021-01735-1. Epub 2021 Dec 2. Infection. 2022. PMID: 34854060
Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids.
Magoulas GE, Afroudakis P, Georgikopoulou K, Roussaki M, Borsari C, Fotopoulou T, Santarem N, Barrias E, Tejera Nevado P, Hachenberg J, Bifeld E, Ellinger B, Kuzikov M, Fragiadaki I, Scoulica E, Clos J, Gul S, Costi MP, de Souza W, Prousis KC, Cordeiro da Silva A, Calogeropoulou T. Magoulas GE, et al. Among authors: scoulica e. Molecules. 2021 Jul 10;26(14):4204. doi: 10.3390/molecules26144204. Molecules. 2021. PMID: 34299479 Free PMC article.
Ceftazidime-avibactam, meropenen-vaborbactam, and imipenem-relebactam in combination with aztreonam against multidrug-resistant, metallo-β-lactamase-producing Klebsiella pneumoniae.
Maraki S, Mavromanolaki VE, Moraitis P, Stafylaki D, Kasimati A, Magkafouraki E, Scoulica E. Maraki S, et al. Among authors: scoulica e. Eur J Clin Microbiol Infect Dis. 2021 Aug;40(8):1755-1759. doi: 10.1007/s10096-021-04197-3. Epub 2021 Feb 17. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33595756
Pasteurella multocida wound infection transmitted by a pet dog.
Maraki S, Kastanis G, Stafylaki D, Masunt S, Kapsetakis P, Scoulica E. Maraki S, et al. Among authors: scoulica e. Germs. 2018 Dec 3;8(4):214-217. doi: 10.18683/germs.2018.1149. eCollection 2018 Dec. Germs. 2018. PMID: 30775341 Free PMC article.
58 results